Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2013

Nov 4, 2013

30718_dirs_2013-11-04_c1e64e4f-7010-4260-9f1b-4cc0eb371172.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2013-10-31

Reporting Person: Nusse Roeland (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-10-31 Common Stock A 1000 Acquired 1000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-10-31 Stock Option $87.39 A 4000 Acquired 2023-10-30 Common Stock (4000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $66.90 2022-10-24 Common Stock (5000) 5000 Direct
Stock Option $70.35 2021-10-26 Common Stock (5000) 5000 Direct
Stock Option $61.46 2020-10-27 Common Stock (5000) 5000 Direct
Stock Option $60.46 2020-05-25 Common Stock (10000) 10000 Direct